173 Odcinki

  1. Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader

    Opublikowany: 26.07.2021

  2. Ep94: Jenny Rooke on Investing in Biotech Tools

    Opublikowany: 19.07.2021

  3. Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists

    Opublikowany: 14.06.2021

  4. Ep92: Brad Gray on Spatial Biology

    Opublikowany: 1.06.2021

  5. Ep91: Daphne Zohar on Biotech Entrepreneurship

    Opublikowany: 3.05.2021

  6. Ep90: James Sabry on Partnering Amid Scientific Abundance

    Opublikowany: 19.04.2021

  7. Ep89: Emily Leproust on DNA Synthesis at Scale

    Opublikowany: 29.03.2021

  8. Ep88: Amy DuRoss on software and logistics for cell and gene therapy

    Opublikowany: 15.03.2021

  9. Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing

    Opublikowany: 1.03.2021

  10. Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease

    Opublikowany: 9.02.2021

  11. Ep85: Luhan Yang on CRISPR Editing for Organ Transplants

    Opublikowany: 20.01.2021

  12. Ep84: Steve Paul on Treatments for Mental Health

    Opublikowany: 22.12.2020

  13. Ep83: David Lee on Impact in Pharmaceuticals

    Opublikowany: 14.12.2020

  14. Ep82: Andrew Farnum on Medicines From Unusual Traits

    Opublikowany: 23.11.2020

  15. Ep81: Simba Gill on Microbiome Therapies

    Opublikowany: 12.11.2020

  16. Ep80: Peter Kolchinsky on Pharma's Soul

    Opublikowany: 28.10.2020

  17. Ep79: Daphne Koller on Machine Learning for Drug Discovery

    Opublikowany: 26.10.2020

  18. Ep78: Pearl Huang on Exoneural Cancer Biology

    Opublikowany: 13.10.2020

  19. Ep77: Jennifer Petter on Drugging RNA Targets

    Opublikowany: 29.09.2020

  20. Ep76: Otello Stampacchia on Becoming a Biotech VC

    Opublikowany: 8.09.2020

5 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site